Symbol Name ID |
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1 MGI:88588 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Increased circulating IgA level |
Increased circulating IgG level |
Decreased circulating antibody level |
Paraproteinemia |
Abnormal erythrocyte enzyme concentration or activity |
Abnormality of metabolism/homeostasis |
Hypercalcemia |
Increased circulating iron concentration |
Elevated circulating creatinine concentration |
Abnormal circulating porphyrin concentration |
Increased circulating ferritin concentration |
Decreased circulating hepcidin concentration |
Hyperproteinemia |
Abnormal circulating enzyme concentration or activity |
Elevated circulating hepatic transaminase concentration |
Reduced leukocyte alkaline phosphatase |
Reduced uroporphyrinogen decarboxylase activity |
Diabetes mellitus |
Type II diabetes mellitus |
Insulin resistance |
Elevated sweat chloride |
Dehydration |
Pleural effusion |
Fever |
Abnormality of vitamin B12 metabolism |
Increased fecal porphyrin |
Elevated hepatic iron concentration |
Hepatic steatosis |
Hypercalciuria |
Hematuria |
Pyuria |
Decreased level of D-mannose in urine |
Increased level of L-fucose in urine |
Increased urinary porphobilinogen |
Proteinuria |
Porphyrinuria |
Amyloidosis |
Increased circulating free T3 |
Increased circulating free T4 concentration |
Decreased thyroid-stimulating hormone level |
Corneal scarring |
Scarring |
Disease(s) Associated with CYP1A1 | ||||||||||||||||||||||||||||||||||||||||||
Behcet's disease | ||||||||||||||||||||||||||||||||||||||||||
chronic myeloid leukemia | ||||||||||||||||||||||||||||||||||||||||||
cystic fibrosis | ||||||||||||||||||||||||||||||||||||||||||
Graves' disease | ||||||||||||||||||||||||||||||||||||||||||
multiple myeloma | ||||||||||||||||||||||||||||||||||||||||||
polycystic ovary syndrome | ||||||||||||||||||||||||||||||||||||||||||
porphyria cutanea tarda | ||||||||||||||||||||||||||||||||||||||||||
Sjogren's syndrome | ||||||||||||||||||||||||||||||||||||||||||
stomach cancer | ||||||||||||||||||||||||||||||||||||||||||
systemic lupus erythematosus | ||||||||||||||||||||||||||||||||||||||||||
type 2 diabetes mellitus |
Mouse Phenotypes | homeostasis/metabolism phenotype |
increased circulating alanine transaminase level |
increased circulating aspartate transaminase level |
decreased susceptibility to xenobiotic induced morbidity/mortality |
decreased physiological sensitivity to xenobiotic |
increased physiological sensitivity to xenobiotic |
abnormal xenobiotic pharmacokinetics |
|
Availability | Mouse Genotype | |||||||
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn | ||||||||
Cyp1a1tm2.1Dwn/Cyp1a1tm2.1Dwn | * | |||||||
Cyp1a1tm3.1Dwn/Cyp1a1tm3.1Dwn | ||||||||
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|